Sustainable nanophytosome-based therapies against multidrug-resistant Escherichia coli in urinary tract infections: an in Vitro and in vivo study

被引:0
|
作者
Wen, Ming Ming [1 ]
Abdelwahab, Ibrahim A. [2 ]
Abozahra, Rania [3 ]
Abdelhamid, Sarah M. [3 ]
Baraka, Kholoud [3 ]
Ahmed, Heba Essam Sedky [4 ]
El-Hadidy, Wessam F. [4 ]
机构
[1] Pharos Univ Alexandria, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Alexandria, Egypt
[2] Pharos Univ Alexandria, Fac Pharm, Dept Microbiol & Immunol, Alexandria, Egypt
[3] Damanhour Univ, Fac Pharm, Dept Microbiol & Immunol, Damanhour, Egypt
[4] Alexandria Univ, Med Res Inst, Dept Pharmacol & Expt Therapeut, Alexandria, Egypt
关键词
Nanophytosomes; Rosemary oil; Escherichia coli; Chitosan; Urinary tract infection; Multidrug resistance; Drug delivery; Sustainability; Herbal medicine; Nanoparticle; CHITOSAN NANOPARTICLES; ESSENTIAL OILS; ROSEMARY; EPIDEMIOLOGY; FORMULATION; MECHANISMS; COMPONENTS; BIOFILM; THYME; ACID;
D O I
10.1186/s12951-024-03006-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Urinary tract infection (UTI) is a prevalent bacterial infection impacting a significant number of individuals globally. The rise in multidrug-resistant (MDR) E. coli strains as the predominant cause of UTIs presents a substantial public health concern and poses a challenge to existing antibiotic treatments. This study introduces an innovative and sustainable therapeutic approach utilizing rosemary oil nanophytosomes as a targeted drug delivery system to address biofilms in UTIs induced by MDR E. coli. Method Seventy clinically identified E. coli isolates from UTI patients were used for this study. Nanophytosomes were formulated with chitosan (CS) and nanostructured lipid carriers. CS-nanophytosomes were lyophilized to evaluate the storage stability. In vivo study included 40 female Wistar rats with daily treatment over seven days. For all the statistical tests, differences were considered significant at p < 0.01 and highly significant at p < 0.001. Results CS-nanophytosomes demonstrated a particle size of 176.70 +/- 12.30 nm with a substantial antibiofilm efficacy against MDR E. coli. High entrapment efficiency was ascertained with 93.12 +/- 1.05%. The drug release study showed that the pure rosemary oil exhibited a notably lower release of 35.4 +/- 2.36% over 48 h. In contrast, the CS-nanophytosomes and lyophilized CS-nanophytosomes displayed significantly higher release percentages of 58.6 +/- 3.69% and 56.9 +/- 5.01%, respectively, compared to the pure rosemary oil of 35.4 +/- 2.36% over 48 h. The in vivo study indicated that nanophytosomes successfully reduced the bacterial load in the urine, bladder, and kidney tissues of mice infected with MDR E. coli, while also lowering the levels of inflammatory cytokines and oxidative stress markers in serum and urine samples. Additionally, the nanophytosomes improved histopathological changes in bladder and kidney tissues caused by UTI without causing any toxicity or adverse effects on kidney function or hematological parameters. Conclusion Our research introduces a cost-effective and innovative approach to addressing UTIs caused by MDR E. coli by the use of rosemary oil, a natural antimicrobial agent encapsulated in nanophytosomes. This strategy not only demonstrates proven therapeutic efficacy in UTI animal models but also promotes the adoption of sustainable medical approaches. CS-nanophytosomes provides a sustainable alternative therapeutic option to combat MDR UTIs.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Development of a Vaccine against Escherichia coli Urinary Tract Infections
    Mobley, Harry L. T.
    Alteri, Christopher J.
    PATHOGENS, 2016, 5 (01): : 1 - 8
  • [32] Multidrug-resistant Escherichia coli causing canine pyometra and urinary tract infections are genetically related but distinct from those causing prostatic abscesses
    Sroithongkham, Parinya
    Nittayasut, Naiyaphat
    Yindee, Jitrapa
    Nimsamer, Pattaraporn
    Payungporn, Sunchai
    Pinpimai, Komkiew
    Ponglowhapan, Suppawiwat
    Chanchaithong, Pattrarat
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [33] The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli
    Can, Fusun
    Kurt-Azap, Ozlem
    Ispir, Pelin
    Nurtop, Elif
    Seref, Ceren
    Loclar, Ilayda
    Aktas, Ozge Nur
    Orhan, Yelda Ceren
    Ergonul, Onder
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2016, 4 : 49 - 52
  • [34] The Prevalence of Multidrug-Resistant Escherichia coli Producing ESBL among Male and Female Patients with Urinary Tract Infections in Riyadh Region, Saudi Arabia
    Abalkhail, Adil
    AlYami, Ahmad S.
    Alrashedi, Saeed F.
    Almushayqih, Khalid M.
    Alslamah, Thamer
    Alsalamah, Yasir Ahmed
    Elbehiry, Ayman
    HEALTHCARE, 2022, 10 (09)
  • [35] Treatment options for multidrug-resistant Gram-negatives in urinary tract infections
    Zollner-Schwetz, Ines
    Koenig, Elisabeth
    CURRENT OPINION IN UROLOGY, 2023, 33 (03) : 173 - 179
  • [36] Widespread distribution of a multidrug-resistant clonal group of E-coli causing urinary tract infections.
    Manges, AR
    Johnson, JR
    Foxman, B
    O'Bryan, TT
    Fullerton, KE
    Riley, LW
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S217 - S217
  • [37] Updates in Management of Complicated Urinary Tract Infections: A Focus on Multidrug-Resistant Organisms
    Ma, Adrienne H.
    Hughes, Gregory J.
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (01) : E53 - E66
  • [38] Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms
    Neuner, Elizabeth A.
    Sekeres, Jennifer
    Hall, Gerri S.
    van Duin, David
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5744 - 5748
  • [39] Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model
    Guo, Siwei
    Li, Xin
    Li, You
    Tong, Huan
    Wei, Minji
    Yan, Bingqian
    Tian, Miaomei
    Xu, Bing
    Shao, Jing
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (01) : 141 - 149
  • [40] Effects of the prebiotic lactoferrin on multidrug-resistant Escherichia coli infections in broiler chickens
    Badr, Heba
    Nabil, Nehal M.
    Tawakol, Maram M.
    VETERINARY WORLD, 2021, 14 (08) : 2197 - 2205